Heath Lukatch - Net Worth and Insider Trading
Heath Lukatch Net Worth
The estimated net worth of Heath Lukatch is at least $705,442 dollars as of 2024-09-21. Heath Lukatch is the Director of Vaxcyte Inc and owns about 5,625 shares of Vaxcyte Inc (PCVX) stock worth over $648,056. Heath Lukatch is also the Director of Inogen Inc and owns about 5,481 shares of Inogen Inc (INGN) stock worth over $57,386. Details can be seen in Heath Lukatch's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Heath Lukatch has not made any transactions after 2024-01-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Heath Lukatch
Heath Lukatch Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Heath Lukatch owns 4 companies in total, including Satsuma Pharmaceuticals Inc (STSA) , Vaxcyte Inc (PCVX) , and Flexion Therapeutics Inc (FLXN) among others .
Click here to see the complete history of Heath Lukatch’s form 4 insider trades.
Insider Ownership Summary of Heath Lukatch
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| STSA | Satsuma Pharmaceuticals Inc | 2019-09-12 | director |
| PCVX | Vaxcyte Inc | 2024-01-31 | director |
| FLXN | Flexion Therapeutics Inc | 2020-06-10 | director |
 | | 2019-08-15 | director & Chairman of the Board |
Heath Lukatch Latest Holdings Summary
Heath Lukatch currently owns a total of 2 stocks. Among these stocks, Heath Lukatch owns 5,625 shares of Vaxcyte Inc (PCVX) as of January 31, 2024, with a value of $648,056 and a weighting of 91.87%. Heath Lukatch also owns 5,481 shares of Inogen Inc (INGN) as of August 15, 2019, with a value of $57,386 and a weighting of 8.13%.
Latest Holdings of Heath Lukatch
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PCVX | Vaxcyte Inc | 2024-01-31 | 5,625 | 115.21 | 648,056 |
| INGN | Inogen Inc | 2019-08-15 | 5,481 | 10.47 | 57,386 |
Holding Weightings of Heath Lukatch
Heath Lukatch Form 4 Trading Tracker
According to the SEC Form 4 filings, Heath Lukatch has made a total of 6 transactions in Vaxcyte Inc (PCVX) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Vaxcyte Inc is the sale of 5,000 shares on January 31, 2024, which brought Heath Lukatch around $357,500.
According to the SEC Form 4 filings, Heath Lukatch has made a total of 0 transactions in Inogen Inc (INGN) over the past 5 years. The most-recent trade in Inogen Inc is the acquisition of 2,000 shares on August 15, 2019, which cost Heath Lukatch around $86,020.
Insider Trading History of Heath Lukatch
- 1
Heath Lukatch Trading Performance
GuruFocus tracks the stock performance after each of Heath Lukatch's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Heath Lukatch is 66.23%. GuruFocus also compares Heath Lukatch's trading performance to market benchmark return within the same time period. The performance of stocks bought by Heath Lukatch within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Heath Lukatch's insider trading performs compared to the benchmark.
Performance of Heath Lukatch
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 12.9 | | | | | |
| Relative Return to S&P 500(%) | 7.29 | | | | | |
Heath Lukatch Ownership Network
Heath Lukatch Owned Company Details
What does Satsuma Pharmaceuticals Inc do?
Who are the key executives at Satsuma Pharmaceuticals Inc?
Heath Lukatch is the director of Satsuma Pharmaceuticals Inc. Other key executives at Satsuma Pharmaceuticals Inc include 10 percent owner Shin Nippon Biomedical Laboratories, Ltd. , director & 10 percent owner Ken Takanashi , and 10 percent owner Braden Michael Leonard .
Satsuma Pharmaceuticals Inc (STSA) Insider Trades Summary
Over the past 18 months, Heath Lukatch made no insider transaction in Satsuma Pharmaceuticals Inc (STSA). Other recent insider transactions involving Satsuma Pharmaceuticals Inc (STSA) include a net purchase of 30,477,313 shares made by Shin Nippon Biomedical Laboratories, Ltd. , and a net purchase of 22,053,581 shares made by Ken Takanashi .
In summary, during the past 3 months, insiders sold 0 shares of Satsuma Pharmaceuticals Inc (STSA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Satsuma Pharmaceuticals Inc (STSA) were sold and 52,530,894 shares were bought by its insiders, resulting in a net purchase of 52,530,894 shares.
Satsuma Pharmaceuticals Inc (STSA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Satsuma Pharmaceuticals Inc Insider Transactions
Heath Lukatch Mailing Address
Above is the net worth, insider trading, and ownership report for Heath Lukatch. You might contact Heath Lukatch via mailing address: 326 Bollay Drive, Goleta Ca 93117.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
